Although recent studies have shown a correlation between clinical depression and heart disease in males, proper management with antidepressants can help prevent cardiovascular diseases.
Electroconvulsive therapy is not a good treatment option because numerous alternative, less harmful interventions are available for the treatment of depressed or severely depressed patients.
Electroconvulsive is an effective treatment option that should remain available for use, with proper ethical safeguards, for the treatment of severe clinical depression.
A new AMA policy provide guidance for physician-scientists on dual-use research issues and reinforces the message that ethical conduct in scientific research ultimately rests with the individual researcher.
Douglas E. Paull, MD, MS and Paul N. Uhlig, MD, MPA
Risk managers can help patient-subjects and clinician-researchers make informed novel device implantation decisions in the absence of preclinical trial data.
AMA J Ethics. 2020;22(11):E911-918. doi:
10.1001/amajethics.2020.911.
The authors of a recent journal article believe that most doctors and clinical trial sponsors would not object to changes in regulations requiring doctors to disclose financial incentives to their patients.